Anthera Pharmaceuticals. Inc.
Q2 2018 13F Holders
Symbol
ANTH
CUSIP
03674U300
Type
Equity
Class
COM
Num filings
5
Total reported value, excl. options
$18.7 k
Compare 2018 Q2 to
2019 Q4
2018 Q3
2018 Q1
2017 Q4
2017 Q3
2017 Q2
2017 Q1
Manager
Report Date
Value ($000)
Shares
Option Type